Correlation Between Lyxor 1 and Esprinet SpA

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Lyxor 1 and Esprinet SpA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lyxor 1 and Esprinet SpA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lyxor 1 and Esprinet SpA, you can compare the effects of market volatilities on Lyxor 1 and Esprinet SpA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lyxor 1 with a short position of Esprinet SpA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lyxor 1 and Esprinet SpA.

Diversification Opportunities for Lyxor 1 and Esprinet SpA

-0.47
  Correlation Coefficient

Very good diversification

The 3 months correlation between Lyxor and Esprinet is -0.47. Overlapping area represents the amount of risk that can be diversified away by holding Lyxor 1 and Esprinet SpA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Esprinet SpA and Lyxor 1 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lyxor 1 are associated (or correlated) with Esprinet SpA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Esprinet SpA has no effect on the direction of Lyxor 1 i.e., Lyxor 1 and Esprinet SpA go up and down completely randomly.

Pair Corralation between Lyxor 1 and Esprinet SpA

Assuming the 90 days trading horizon Lyxor 1 is expected to generate 0.37 times more return on investment than Esprinet SpA. However, Lyxor 1 is 2.69 times less risky than Esprinet SpA. It trades about 0.05 of its potential returns per unit of risk. Esprinet SpA is currently generating about -0.21 per unit of risk. If you would invest  2,424  in Lyxor 1 on October 5, 2024 and sell it today you would earn a total of  57.00  from holding Lyxor 1 or generate 2.35% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Lyxor 1   vs.  Esprinet SpA

 Performance 
       Timeline  
Lyxor 1 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Insignificant
Over the last 90 days Lyxor 1 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Lyxor 1 is not utilizing all of its potentials. The latest stock price disturbance, may contribute to mid-run losses for the stockholders.
Esprinet SpA 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Esprinet SpA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Lyxor 1 and Esprinet SpA Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Lyxor 1 and Esprinet SpA

The main advantage of trading using opposite Lyxor 1 and Esprinet SpA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lyxor 1 position performs unexpectedly, Esprinet SpA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Esprinet SpA will offset losses from the drop in Esprinet SpA's long position.
The idea behind Lyxor 1 and Esprinet SpA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Complementary Tools

Fundamental Analysis
View fundamental data based on most recent published financial statements
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities